$GTCH
GBT Technologies Inc. Stock $gtch

$gtch Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000173112224001804 Filed on November 14, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin		$75.79K
YoY Change		-40.63%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$198.6K
YoY Change		-37.43%
Operating Profit		-$198.6K
YoY Change		-37.43%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net		$6.475M
YoY Change		2184.37%
Pretax Income		$6.276M
YoY Change		-18567.79%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings		$6.284M
YoY Change		-8759.65%
Net Earnings / Revenue
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share		$0.00
COMMON SHARES
Basic Shares Outstanding	16.81B shares	16.81B shares
Diluted Shares Outstanding		27.63B shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$11.05K
YoY Change		-71.74%
Cash & Equivalents		$1.505K
Short-Term Investments		$9.546K
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets		$57.30K
YoY Change		-76.11%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets		$57.30K
Total Long-Term Assets		$0.00
Total Assets		$57.30K
YoY Change		-76.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$790.0K
YoY Change		-30.91%
Accrued Expenses		$0.00
YoY Change		-100.0%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$16.09M
YoY Change		-47.35%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$328.7K
YoY Change		5.29%
TOTAL LIABILITIES
Total Short-Term Liabilities		$16.09M
Total Long-Term Liabilities		$328.7K
Total Liabilities		$16.42M
YoY Change		-46.81%
SHAREHOLDERS EQUITY
Retained Earnings		-$301.5M
YoY Change		-4.24%
Common Stock		$168.1K
YoY Change		143.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$11.06K
YoY Change		-98.28%
Treasury Stock Shares
Shareholders Equity		-$15.31M
YoY Change
Total Liabilities & Shareholders Equity		$57.30K
YoY Change		-76.11%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		$6.284M
YoY Change		-8759.65%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Address Address Line1 EntityAddressAddressLine1	8557 N West Knoll Dr.
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Central Index Key EntityCentralIndexKey	0001471781
CY2023Q4	us-gaap	Cash Cash	529	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	31206	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	77985	usd
CY2023Q4	us-gaap	Assets Assets	77985	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5372846	usd
CY2023Q4	GTCH	Accounts Payable And Accrued Expenses Related Party Current AccountsPayableAndAccruedExpensesRelatedPartyCurrent	1767710	usd
CY2023Q4	GTCH	Accrued Settlement AccruedSettlement	4090057	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	5665017	usd
CY2023Q4	GTCH	Convertible Note Payable ConvertibleNotePayable	661395	usd
CY2023Q4	GTCH	Note Payable Current NotePayableCurrent	46532	usd
CY2023Q4	GTCH	Note Payable Related Parties Classified Current NotePayableRelatedPartiesClassifiedCurrent	140000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	328748	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	102538	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	11059	usd
CY2023Q4	GTCH	Shares To Be Cancelled SharesToBeCancelled	-632000	usd
CY2023Q4	GTCH	Stock Loan Receivable StockLoanReceivable	-7610147	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	293069829	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-315993294	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-31074133	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-1036249	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-32110382	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	77985	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18120	usd
	dei	Entity File Number EntityFileNumber	000-54530
	dei	Entity Registrant Name EntityRegistrantName	GBT TECHNOLOGIES INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-0603137
	dei	Entity Address City Or Town EntityAddressCityOrTown	West Hollywood
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90069
	dei	City Area Code CityAreaCode	888
	dei	Local Phone Number LocalPhoneNumber	685-7336
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16813229180	shares
CY2024Q3	us-gaap	Cash Cash	1505	usd
CY2024Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	46250	usd
CY2024Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	9546	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	57301	usd
CY2024Q3	us-gaap	Assets Assets	57301	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2634471	usd
CY2024Q3	GTCH	Accounts Payable And Accrued Expenses Related Party Current AccountsPayableAndAccruedExpensesRelatedPartyCurrent	2911941	usd
CY2024Q3	GTCH	Accrued Settlement AccruedSettlement	4090057	usd
CY2024Q3	GTCH	Debt Instrument Unamortized Discount Currents DebtInstrumentUnamortizedDiscountCurrents	0	usd
CY2023Q4	GTCH	Debt Instrument Unamortized Discount Currents DebtInstrumentUnamortizedDiscountCurrents	43739	usd
CY2024Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	5131491	usd
CY2024Q3	GTCH	Debt Instrument Payable To Related Party Unamortized Discount Current DebtInstrumentPayableToRelatedPartyUnamortizedDiscountCurrent	0	usd
CY2023Q4	GTCH	Debt Instrument Payable To Related Party Unamortized Discount Current DebtInstrumentPayableToRelatedPartyUnamortizedDiscountCurrent	0	usd
CY2024Q3	GTCH	Convertible Note Payable ConvertibleNotePayable	491395	usd
CY2024Q3	GTCH	Notes Payable Unamortized Discount Current NotesPayableUnamortizedDiscountCurrent	0	usd
CY2023Q4	GTCH	Notes Payable Unamortized Discount Current NotesPayableUnamortizedDiscountCurrent	2265	usd
CY2024Q3	GTCH	Note Payable Current NotePayableCurrent	21252	usd
CY2024Q3	GTCH	Note Payable Related Parties Classified Current NotePayableRelatedPartiesClassifiedCurrent	140000	usd
CY2024Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	665941	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16813229180	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16813229180	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10253695062	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10253695062	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	168133	usd
CY2024Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	21	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	21	shares
CY2024Q3	us-gaap	Treasury Stock Value TreasuryStockValue	11059	usd
CY2024Q3	GTCH	Shares To Be Cancelled SharesToBeCancelled	-632000	usd
CY2024Q3	GTCH	Stock Loan Receivable StockLoanReceivable	-7610147	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	294255052	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-301481439	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-15311460	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	-1046536	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-16357995	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57301	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	47359	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24588	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	287688	usd
CY2024Q3	us-gaap	Marketing Expense MarketingExpense	57672	usd
CY2023Q3	us-gaap	Marketing Expense MarketingExpense	80311	usd
	us-gaap	Marketing Expense MarketingExpense	147912	usd
	us-gaap	Marketing Expense MarketingExpense	192308	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	122815	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	189749	usd
	us-gaap	Professional Fees ProfessionalFees	360815	usd
	us-gaap	Professional Fees ProfessionalFees	607509	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	198607	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	317419	usd
	us-gaap	Operating Expenses OperatingExpenses	533315	usd
	us-gaap	Operating Expenses OperatingExpenses	1087505	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-198607	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-317419	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-533315	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1087505	usd
CY2023Q3	GTCH	Amortization Of Financing Cost AmortizationOfFinancingCost	29927	usd
	GTCH	Amortization Of Financing Cost AmortizationOfFinancingCost	46003	usd
	GTCH	Amortization Of Financing Cost AmortizationOfFinancingCost	298348	usd
CY2024Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	4004405	usd
CY2023Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	365121	usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2024Q2	GTCH	Visionwave Investment Reclassification VisionwaveInvestmentReclassification		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	46250	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	14116062	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	16086548	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	31859619	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	0	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	0	usd
CY2024Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	328748	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	328748	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	328748	usd
CY2024Q3	us-gaap	Liabilities Liabilities	16415296	usd
CY2023Q4	us-gaap	Liabilities Liabilities	32188367	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000000	shares
CY2024Q3	GTCH	Amortization Of Financing Cost AmortizationOfFinancingCost	2656	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	12755202	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-12663365	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	175962	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	156497	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	322560	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	2111400	usd
CY2024Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-10000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-10000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	315297	usd
CY2023Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	38385	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	38385	usd
CY2024Q3	GTCH	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities	63	usd
	GTCH	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities	732	usd
	GTCH	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities	3692	usd
CY2024Q3	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	2658977	usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	2658977	usd
CY2024Q3	GTCH	Other Income Related Party Licensing Income OtherIncomeRelatedPartyLicensingIncome	0	usd
CY2023Q3	GTCH	Other Income Related Party Licensing Income OtherIncomeRelatedPartyLicensingIncome	66353	usd
	GTCH	Other Income Related Party Licensing Income OtherIncomeRelatedPartyLicensingIncome	0	usd
	GTCH	Other Income Related Party Licensing Income OtherIncomeRelatedPartyLicensingIncome	269553	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6474701	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	283435	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	15034884	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14453570	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6276094	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-33984	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	14501569	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15541075	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	6276094	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-33984	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	14501569	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-15541075	usd
CY2024Q3	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	0	usd
CY2023Q3	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	-38385	usd
	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	0	usd
	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	-38385	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	6276094	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-72369	usd
	us-gaap	Profit Loss ProfitLoss	14501569	usd
	us-gaap	Profit Loss ProfitLoss	-15579460	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-7523	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	193	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-10287	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	43807	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	6283617	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-72562	usd
	us-gaap	Net Income Loss NetIncomeLoss	14511856	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15623267	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16813229180	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5342065441	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16261212589	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4462434507	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27631580912	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28665913915	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27079564321	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27786282982	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-32110382	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	557561	usd
CY2024Q1	GTCH	Fair Value Of Derivative Liability Due To Conversions FairValueOfDerivativeLiabilityDueToConversions	694919	usd
CY2024Q1	GTCH	Tokenize Investment Reclassification TokenizeInvestmentReclassification	-1660	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7159889	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-23699672	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1073109	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-22626566	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6268571	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-16357995	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-18830908	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	403548	usd
CY2023Q1	GTCH	Fair Value Of Derivative Liability Due To Conversions FairValueOfDerivativeLiabilityDueToConversions	316223	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	80000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5629713	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-23660850	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	881372	usd
CY2023Q2	GTCH	Fair Value Of Derivative Liability Due To Conversions FairValueOfDerivativeLiabilityDueToConversions	1686461	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9833571	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-30926588	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	115000	usd
CY2023Q3	GTCH	Fair Value Of Derivative Liability Due To Conversions FairValueOfDerivativeLiabilityDueToConversions	260109	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-72369	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-30623848	usd
	us-gaap	Profit Loss ProfitLoss	14501569	usd
	us-gaap	Profit Loss ProfitLoss	-15579460	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	46003	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	298348	usd
	GTCH	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	-12755202	usd
	GTCH	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	12663365	usd
	GTCH	Excess Of Debt Discount And Financing Costs ExcessOfDebtDiscountAndFinancingCosts	0	usd
	GTCH	Excess Of Debt Discount And Financing Costs ExcessOfDebtDiscountAndFinancingCosts	1500196	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	80000	usd
	GTCH	Change In Fair Value Of Marketable Security ChangeInFairValueOfMarketableSecurity	10000	usd
	GTCH	Change In Fair Value Of Marketable Security ChangeInFairValueOfMarketableSecurity	3692	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2658977	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	315297	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-0	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-0	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	2297	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-0	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-12500	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-0	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-0	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-0	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-0	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-74921	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-41444	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-229102	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1382820	usd
	GTCH	Increase Decrease In Accounts Payable And Accrued Liabilities Rp IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRP	1114231	usd
	GTCH	Increase Decrease In Accounts Payable And Accrued Liabilities Rp IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRP	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	28522	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-72498	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	92150	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	27546	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	61071	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	-0	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	27375	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	-0	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	35822	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	92150	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-27546	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	60032	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	976	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-12466	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	529	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13058	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1505	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	592	usd
	us-gaap	Interest Paid InterestPaid	0	usd
	us-gaap	Interest Paid InterestPaid	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	GTCH	Reduction In Derivative Liability Due To Conversion ReductionInDerivativeLiabilityDueToConversion	694919	usd
	GTCH	Reduction In Derivative Liability Due To Conversion ReductionInDerivativeLiabilityDueToConversion	63379	usd
	GTCH	Shares Issued For Conversion Of Convertible Debt SharesIssuedForConversionOfConvertibleDebt	557560	usd
	GTCH	Shares Issued For Conversion Of Convertible Debt SharesIssuedForConversionOfConvertibleDebt	2002684	usd
	GTCH	Debt Discount Related To Convertible Debt DebtDiscountRelatedToConvertibleDebt	0	usd
	GTCH	Debt Discount Related To Convertible Debt DebtDiscountRelatedToConvertibleDebt	1284920	usd
	GTCH	Visionwave Investment Reclassifications VisionwaveInvestmentReclassifications	0	usd
	GTCH	Visionwave Investment Reclassifications VisionwaveInvestmentReclassifications	0	usd
	GTCH	Tokenize Investment Reclassifications TokenizeInvestmentReclassifications	1660	usd
	GTCH	Tokenize Investment Reclassifications TokenizeInvestmentReclassifications	0	usd
CY2021Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 50
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q3	us-gaap	Common Unit Authorized CommonUnitAuthorized	10000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000000	shares
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-301481439	usd
CY2024Q3	GTCH	Working Capital Deficit WorkingCapitalDeficit	16029247	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_z8LGe0R3IAzc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86A_zZC2PdKxxIJf">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying condensed consolidated financial statements include valuation of derivatives and valuation allowance on deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	0	usd
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	0	usd
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_843_eus-gaap--DerivativesReportingOfDerivativeActivity_z2B517Mip547" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86C_zYqc5BqaWlhj">Derivative Financial Instruments</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its FV and is then re-valued at each reporting date, with changes in the FV reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of September 30, 2024 and December 31, 2023, the Company’s only derivative financial instrument was an embedded conversion feature associated with convertible notes payable due to certain provisions that allow for a change in the conversion price based on a percentage of the Company’s stock price at the date of conversion.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q3	GTCH	Conversion Feature On Convertible Notes ConversionFeatureOnConvertibleNotes	665941	usd
CY2023Q4	GTCH	Conversion Feature On Convertible Notes ConversionFeatureOnConvertibleNotes	14116062	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_846_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zHJC1MhbzCyf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_864_zV5mVkthYy71">Reclassification</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective July 1, 2023, the Company terminated its joint venture revenue sharing (“Termination Agreement”) with Mahaser LTD (“Mahaser”). Until June 30, 2023, the Company’s variable interests in Mahaser obligate the Company to absorb deficits and provide it with the right to receive benefits that could potentially be significant to Mahaser. The Company evaluated for the period ended on June 30, 2023, whether it has a variable interest in Mahaser, whether Mahaser is a VIE and whether the Company has a controlling financial interest in Mahaser. The Company concluded that it has variable interests in Mahaser on the basis of GBT has 100% control over the JV/revenue sharing, and as such should consolidate the JV into its books and records as it assigned 100% financial responsibility. Mahaser’s equity at risk, as defined by GAAP, is considered to be insufficient to finance its activities without additional support, and, therefore, Mahaser is considered a VIE. As termination Agreement took place during the reporting period, the financial been classified to disclose this operation as discontinued operation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q1	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	200000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10818351732	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	75975606634	shares
CY2024Q3	us-gaap	Marketable Securities MarketableSecurities	9546	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	31206	usd
	GTCH	Note Payable Description NotePayableDescription	Note payable by Gopher Protocol Costa Rica Sociedad De Responsabilidad Limitada to the Company in the principal amount of $5,000,000 dated February 6, 2019 (of which the underlying security for this Promissory Note is 30,000,000 restricted shares of common stock of Mobiquity Technologies, Inc. (“Mobiquity”) and 60,000,000 restricted shares of common stock of Mobiquity.
CY2020Q1	GTCH	Services Payable ServicesPayable	33333	usd
CY2020Q1	GTCH	Impairment Charge ImpairmentCharge	5500000	usd
CY2021Q4	GTCH	Impairment Charge ImpairmentCharge	15400000	usd
CY2024Q3	us-gaap	Investments Investments	0	usd
CY2023Q4	us-gaap	Investments Investments	0	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	790043	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	773974	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	0	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	499492	usd
CY2024Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1844429	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	4099380	usd
CY2024Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	2634472	usd
CY2023Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	5372846	usd
CY2024Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	659000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	490000	usd
CY2024Q3	us-gaap	Accrued Liabilities Fair Value Disclosure AccruedLiabilitiesFairValueDisclosure	4100000	usd
CY2024Q3	GTCH	Accounts Payable Related Parties AccountsPayableRelatedParties	1070000	usd
CY2023Q4	GTCH	Accounts Payable Related Parties AccountsPayableRelatedParties	770000	usd
CY2024Q3	GTCH	Accrued Interest Related Parties AccruedInterestRelatedParties	144644	usd
CY2023Q4	GTCH	Accrued Interest Related Parties AccruedInterestRelatedParties	96115	usd
CY2024Q3	GTCH	Other Payables Related Parties OtherPayablesRelatedParties	1697297	usd
CY2023Q4	GTCH	Other Payables Related Parties OtherPayablesRelatedParties	901595	usd
CY2024Q3	GTCH	Accounts Payable And Accrued Expenses Related Party Current AccountsPayableAndAccruedExpensesRelatedPartyCurrent	2911941	usd
CY2023Q4	GTCH	Accounts Payable And Accrued Expenses Related Party Current AccountsPayableAndAccruedExpensesRelatedPartyCurrent	1767710	usd
CY2024Q3	GTCH	Accounts Payable Related Parties AccountsPayableRelatedParties	1070000	usd
CY2024Q3	GTCH	Other Payable Related Parties OtherPayableRelatedParties	1700000	usd
CY2024Q3	us-gaap	Convertible Debt ConvertibleDebt	5131491	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	5708756	usd
CY2024Q3	GTCH	Debt Instruments Unamortized Discount Noncurrent DebtInstrumentsUnamortizedDiscountNoncurrent	-0	usd
CY2023Q4	GTCH	Debt Instruments Unamortized Discount Noncurrent DebtInstrumentsUnamortizedDiscountNoncurrent	-43739	usd
CY2024Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	5131491	usd
CY2023Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	5665017	usd
CY2024Q3	GTCH	Less Current Portion LessCurrentPortion	5131491	usd
CY2023Q4	GTCH	Less Current Portion LessCurrentPortion	5665017	usd
CY2024Q3	GTCH	Convertible Notes Payable Longterm Portion ConvertibleNotesPayableLongtermPortion	0	usd
CY2023Q4	GTCH	Convertible Notes Payable Longterm Portion ConvertibleNotesPayableLongtermPortion	0	usd
CY2021	GTCH	Charge Related To Modification Of Debt ChargeRelatedToModificationOfDebt	13777480	usd
	GTCH	Convertible Note Payable Description ConvertibleNotePayableDescription	IGOR 1 converted $195,500 of the convertible note into 2,300,000,000 shares of the Company’s common stock.
CY2024Q3	GTCH	Convertible Note Payable To Stanley Hills ConvertibleNotePayableToStanleyHills	491395	usd
CY2023Q4	GTCH	Convertible Note Payable To Stanley Hills ConvertibleNotePayableToStanleyHills	661395	usd
CY2024Q3	GTCH	Unamortized Debt Discount At Convertible Note Payable UnamortizedDebtDiscountAtConvertibleNotePayable	0	usd
CY2023Q4	GTCH	Unamortized Debt Discount At Convertible Note Payable UnamortizedDebtDiscountAtConvertibleNotePayable	0	usd
CY2024Q3	GTCH	Other Convertible Notes Payable Current OtherConvertibleNotesPayableCurrent	491395	usd
CY2023Q4	GTCH	Other Convertible Notes Payable Current OtherConvertibleNotesPayableCurrent	661395	usd
CY2024Q3	GTCH	Less Current Portion Of Convertible Note Payable LessCurrentPortionOfConvertibleNotePayable	-491395	usd
CY2023Q4	GTCH	Less Current Portion Of Convertible Note Payable LessCurrentPortionOfConvertibleNotePayable	-661395	usd
CY2024Q3	GTCH	Convertible Notes Payable Net Related Party Longterm Portion ConvertibleNotesPayableNetRelatedPartyLongtermPortion	0	usd
CY2023Q4	GTCH	Convertible Notes Payable Net Related Party Longterm Portion ConvertibleNotesPayableNetRelatedPartyLongtermPortion	0	usd
CY2024Q3	GTCH	Total Notes Payables TotalNotesPayables	350000	usd
CY2023Q4	GTCH	Total Notes Payables TotalNotesPayables	377546	usd
CY2024Q3	GTCH	Debt Instruments Unamortized Discount Current DebtInstrumentsUnamortizedDiscountCurrent	0	usd
CY2023Q4	GTCH	Debt Instruments Unamortized Discount Current DebtInstrumentsUnamortizedDiscountCurrent	-2265	usd
CY2024Q3	GTCH	Note Payables NotePayables	350000	usd
CY2023Q4	GTCH	Note Payables NotePayables	375281	usd
CY2024Q3	GTCH	Current Portion Of Notes Payables CurrentPortionOfNotesPayables	-21252	usd
CY2023Q4	GTCH	Current Portion Of Notes Payables CurrentPortionOfNotesPayables	-46533	usd
CY2024Q3	GTCH	Long Term Note Payables LongTermNotePayables	328748	usd
CY2023Q4	GTCH	Long Term Note Payables LongTermNotePayables	328748	usd
	GTCH	Schedule Of Note Payable Related Parties Table Textblock ScheduleOfNotePayableRelatedPartiesTableTextblock	<table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--ScheduleOfNotePayableRelatedPartiesTableTextblock_zlcQajVVB2Sj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes Payable, Non-related Parties and Related Party (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BF_zUxiMobSfUJa" style="display: none">Schedule of notes payable, related parties</span></td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td> </td> <td colspan="3" style="text-align: center">September 30,</td><td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Alpha Eda Note payable</td><td style="width: 8%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--TotalNotesPayableRelatedParty_iI_pp0p0_c20240930__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_zH7UEFg06Buf" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total notes payable, related party">140,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 8%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--TotalNotesPayableRelatedParty_iI_pp0p0_c20231231__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_zqN89AlobiGc" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total notes payable, related party">140,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total notes payable, related party</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--TotalNotesPayableRelatedParty_iI_pp0p0_c20240930_z9ah06bnvtlc" style="text-align: right" title="Total notes payable, related party">140,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--TotalNotesPayableRelatedParty_iI_pp0p0_c20231231_zWkuNQIeaZ97" style="text-align: right" title="Total notes payable, related party">140,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Unamortized debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--DebtInstrumentsUnamortizedDiscountCurrents_iI_pp0p0_d0_c20240930_zEKMwYmF7zGl" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--DebtInstrumentsUnamortizedDiscountCurrents_iI_pp0p0_d0_c20231231_z3mFs9FcKSGg" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Notes payable, net, related party</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--NotesPayableRelatedParties_iI_pp0p0_c20240930_zijTAWAUdU15" style="text-align: right" title="Notes payable, net, related party">140,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--NotesPayableRelatedParties_iI_pp0p0_c20231231_ztJrtZoDMyq4" style="text-align: right" title="Notes payable, net, related party">140,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--CurrentPortionOfNotePayableRelatedParties_iI_pp0p0_c20240930_z8ES9BUuvjCc" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(140,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_ecustom--CurrentPortionOfNotePayableRelatedParties_iI_pp0p0_c20231231_zSNfOx7YOwD2" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(140,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Notes payable, net, related party, long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--NotesPayableNetRelatedPartyLongtermPortion_iI_pp0p0_d0_c20240930_zkiZTg54PVVf" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable, net, related party, long-term portion">—</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--NotesPayableNetRelatedPartyLongtermPortion_iI_pp0p0_d0_c20231231_z8AdwDn7yVa5" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable, net, related party, long-term portion">—</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2024Q3	GTCH	Total Notes Payable Related Party TotalNotesPayableRelatedParty	140000	usd
CY2023Q4	GTCH	Total Notes Payable Related Party TotalNotesPayableRelatedParty	140000	usd
CY2024Q3	GTCH	Debt Instruments Unamortized Discount Currents DebtInstrumentsUnamortizedDiscountCurrents	0	usd
CY2023Q4	GTCH	Debt Instruments Unamortized Discount Currents DebtInstrumentsUnamortizedDiscountCurrents	0	usd
CY2024Q3	GTCH	Notes Payable Related Parties NotesPayableRelatedParties	140000	usd
CY2023Q4	GTCH	Notes Payable Related Parties NotesPayableRelatedParties	140000	usd
CY2024Q3	GTCH	Current Portion Of Note Payable Related Parties CurrentPortionOfNotePayableRelatedParties	-140000	usd
CY2023Q4	GTCH	Current Portion Of Note Payable Related Parties CurrentPortionOfNotePayableRelatedParties	-140000	usd
CY2024Q3	GTCH	Notes Payable Net Related Party Longterm Portion NotesPayableNetRelatedPartyLongtermPortion	0	usd
CY2023Q4	GTCH	Notes Payable Net Related Party Longterm Portion NotesPayableNetRelatedPartyLongtermPortion	0	usd
CY2024Q3	GTCH	Accrued Settlement Payable AccruedSettlementPayable	4090057	usd
CY2023Q4	GTCH	Accrued Settlement Payable AccruedSettlementPayable	4090057	usd
CY2024Q3	GTCH	Accrued Settlement AccruedSettlement	4090057	usd
CY2023Q4	GTCH	Accrued Settlement AccruedSettlement	4090057	usd
CY2024Q3	GTCH	Accrued Settlement AccruedSettlement	4090057	usd
CY2023Q4	GTCH	Accrued Settlement AccruedSettlement	4090057	usd
CY2024Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.0001
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.0002
CY2024Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.000085
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	14116062	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues	0	usd
	GTCH	Fair Value Of Beneficial Conversion Feature Of Debt Converted FairValueOfBeneficialConversionFeatureOfDebtConverted	694919	usd
	GTCH	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Los FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos	-12755202	usd
CY2024Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	665941	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000000	shares
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	6559534118	shares
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	555680	usd
	GTCH	Debt Conversion Converted Instrument Accrued Interest DebtConversionConvertedInstrumentAccruedInterest	1880	usd
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16813229180	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16813229180	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10253695062	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10253695062	shares
CY2024Q3	GTCH	Treasury Shares Issued TreasurySharesIssued	8	shares
CY2023Q4	GTCH	Treasury Shares Issued TreasurySharesIssued	8	shares
CY2024Q3	us-gaap	Treasury Stock Value TreasuryStockValue	11059	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	11059	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	400	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1595
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y7D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	400	shares
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1595
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y7D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	400	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1595
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y7D
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p id="xdx_808_eus-gaap--LossContingencyDisclosures_zagRkj8OYLS7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 15 - <span id="xdx_82A_zR5rO0JDDMKj">Contingencies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>GBT Technologies, S.A.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On September 14, 2018, the Company entered into an Exclusive Intellectual Property License and Royalty Agreement (the “GBT License Agreement”) with GBT-CR, a fully compliant and regulated crypto currency exchange platform that currently operates in Costa Rica as a decentralized crypto currency platform, pursuant to which, among other things, the Company granted to GBT-CR an exclusive, royalty-bearing right and license relating intellectual property relating to systems and methods of converting electronic transmissions into digital currency as reflected in that certain patent filed with the United Stated Patent and Trademark Office on or about June 14, 2018 (EFS ID: 32893586; Application Number: 16008069; Type: Utility under 35 USC 111(a); Confirmation Number: 6787)(collectively, the “Digital Currently Technology”). Pursuant to the GBT License Agreement, the Company granted GBT-CR an exclusive worldwide license to use the Digital Currency Technology to make, use, sell, lease or otherwise commercialize and dispose of products and devices utilizing the Digital Currently Technology. Under the terms of the GBT License Agreement, the Company is entitled to receive a royalty payment of 2% of gross revenue of each licensed product sold by GBT-CR during the period starting in which revenue is first generated using the licensed products and continuing for five years thereafter. Upon signing the GBT-CR License Agreement, GBT-CR paid the Company $<span id="xdx_902_eus-gaap--Revenues_c20180913__20180914__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zZzhiwbN5HMi" title="Revenues">300,000</span> which is nonrefundable. The Company recognized the $<span id="xdx_90C_eus-gaap--Revenues_c20180101__20181231__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zp2XY4SD4LP7" title="Revenues">300,000</span> as revenue during the years ended December 31, 2018. Upon GBT-CR making available for sale (the “Commercial Event”) an ICO (Initial Coin Offering) (the “Coin”), GBT-CR will make a payment to the Company of $<span id="xdx_90D_ecustom--PaymentForExpenses_c20180913__20180914__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zn1w0bf4nal4" title="Payment for expenses">5,000,000</span>. Further, upon the Commercial Event, GBT-CR will grant the Company the ability to acquire 30% of the Coin at a 30% discount of such offering price of the Coin. The GBT License Agreement commenced as of the signing date and, unless terminated in accordance with the termination provisions of the GBT License Agreement, shall remain in force until the expiration of the patent pertaining to the Digital Currency Technology; provided that the right to use trade secrets shall survive the expiration of the GBT License Agreement provided the Company has not terminated. Prior to the signing of the GBT License Agreement, GBT-CR advanced $<span id="xdx_901_eus-gaap--DeferredRevenue_iI_c20180914__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zrC6jHwZPgm7" title="Unearned revenue">200,000</span> to the Company, which the parties have agreed will be applied toward the $<span id="xdx_90B_ecustom--DueToRelatedPartyFees_iI_c20180914__dei--LegalEntityAxis__custom--GBTTechnologiesMember_z47YnwwJ8yn7" title="Due to related party fees">5,000,000</span> fee when it becomes due. On February 27, 2020 GBT Technologies, S.A., as successor in interest to Hermes Roll, LLC had notified the Company that it was in default on its Amended and Restated Territorial License Agreement (“ARTLA”) dated June 15, 2015 and that the ARTLA had been cancelled and rescinded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Stock Loan Receivable</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On January 8, 2019, the Company entered into a Stock Pledge Agreement with Latin American Exchange Latinex Casa de Cambio, S.A., a Costa Rica corporation (“Latinex”), to provide that Latinex may maintain its required regulatory capital as required by various regulators. The Company pledged <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190107__20190108__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_zKPYc7wbfq4a" title="Restricted shares">4,006</span> restricted shares of its common stock valued at $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20190107__20190108__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_z9f3JjtU0i05" title="Value of restricted shares">7,610,147</span> (based on the closing price on the grant date) for three years for an annual payment of $<span id="xdx_901_ecustom--AnnualPayment_iI_c20190108__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_zuOj3DYFMc7l" title="Annual payment">375,000</span> paid in quarterly installments of $<span id="xdx_908_eus-gaap--DebtInstrumentPeriodicPayment_c20190107__20190108__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_zZa8HovZinD4" title="Principal periodic payments">93,750</span>. In lieu of cash payment, Latinex may pay the Company in virtual currency of WISE Network S.A. valued at a 50% discount of its offering price of $10 per token. In the event that Latinex’s required capital has decreased below $5,000,000, Latinex is permitted to sell the pledged shares of common stock only in an amount to ensure that Latinex can satisfy the required capital levels. The Company must consent to such sale of the shares of common stock, which may not be unreasonably withheld. Upon expiration of the agreement, the remaining shares of common stock shall be returned to the Company free and clear of all liens. The Company recorded the value of these shares of common stock as a stock loan receivable which is presented as a contra-equity account in the accompanying consolidated balance sheets. At December 31, 2019, the Company wrote off the accrued interest income as Latinex did not perform any payment and the Company has no mean to enforce this payment. Latinex agreed in principle to return the pledged <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_c20190107__20190108__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_zveB5yiNL53e" title="Cancellation of restricted shares">4,006</span> restricted shares to the Company for cancellation. The <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_zpQWIeL9rh41" title="Restricted shares">4,006</span> restricted shares have not yet been returned to the Company as of September 30, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Metaverse Agreements</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 10, 2022, the Company, entered into a Joint Venture and Territorial License Agreement (the “Metaverse Agreement”) with Ildar Gainulin and Maria Belova (collectively, the “Licensor”). Under the Metaverse Agreement, the parties formed Metaverse Kit Corp., a Nevada corporation (“Metaverse Kit”). The purpose of Metaverse Kit was to develop, maintain and support source codes for its proprietary technologies and comprehensive platform that combines a core virtual reality platform and an extended set of real-world functions to provide a metaverse experience initially within the area of sports and then expanding into virtual worlds of entertainment, live events, gaming, communications and other cross over product opportunities (the “Meta Portfolio”). Under the Metaverse Agreement, Licensor agreed to provide Metaverse Kit with the licensed technology and expertise. In connection therewith, the parties entered an Asset Purchase Agreement (the “Metaverse APA”) concurrently with the Metaverse Agreement whereby Licensor sold Metaverse Kit all source codes pertaining to the Meta Portfolio. Further, Licensor provided an exclusive license to Metaverse Kit throughout the world for the invented product/service and the related platforms relating to the Meta Portfolio and to use the know how to develop, manufacture, sell, market and distribute the Meta Portfolio throughout the world. The Company was required to contribute <span id="xdx_906_eus-gaap--SharesIssued_iI_c20220610__us-gaap--TypeOfArrangementAxis__custom--MetaverseAgreementsMember_zk4zOq5AKZP7" title="Share issued">500,000,000</span> shares of common stock of the Company (“GBT Shares”) to Metaverse Kit. Licensor and the Company were to each own 50% of Metaverse Kit. The Company pledged its <span id="xdx_90B_ecustom--MinorityInterestsOwnershipPercentageByParent_iI_dp_c20220610__us-gaap--TypeOfArrangementAxis__custom--MetaverseAgreementsMember_zHNhJETlX479" title="Ownership percentage">50</span>% ownership in Metaverse Kit to Igor 1 Corp. to secure a convertible note held by Igor 1 Corp. The Company was to appoint two directors and Licensor was allowed to appoint one director of Metaverse Kit. In addition, Metaverse Kit, Licensor and Elentina Group, LLC (“Elentina”) entered into a Consulting Agreements in which IGBM and Elentina, each were engaged to provide services for $<span id="xdx_904_ecustom--PaymentForServices_c20220609__20220610__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementsMember_zlfytvOODkf5" title="Payment for services">25,000</span> per month payable quarterly which Metaverse Kit has the option to pay in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Licensor and Elentina were to provide services in connection with the development of the business as well as Metaverse Kit’s capital raising efforts. The term of the Consulting Agreement was two years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The closing of the Metaverse Agreement occurred on June 13, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On March 14, 2023, the Company received a counter signed Settlement Agreement and Release by Licensor dated March 2, 2023 (“Settlement Agreement”). Pursuant to the Settlement Agreement, the parties agreed that Metaverse Agreement, the Metaverse APA and the Consulting Agreement are void and cancelled. Licensor agreed to pay $<span id="xdx_905_ecustom--PaymentForSettlement_c20230313__20230314__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zC8SnvR73Vm1" title="Payment for settlement">5,000</span> to the Company as settlement payment and surrender their shares in Metaverse Kit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On February 1, 2023, the Company engaged AlKhatib Consulting Group to provide exclusive representation services in connect with managing market partners, effective on February 1, 2023 for 24 consecutive months till 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Assets Sale - TREN</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 3, 2023, GBT Tokenize Corp. (“Seller”), a subsidiary that is owned <span id="xdx_900_ecustom--MinorityInterestsOwnershipPercentageByParent_iI_dp_c20230403__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zFUSJLuME1Hc" title="Ownership percentage">50</span>% by the Company, entered into an agreement to sell certain assets relating to a proprietary system and method named Avant-Ai to TREN. Avant-Ai is a text-generation, deep learning self-training model. In exchange for the assets, TREN is required to issue <span id="xdx_90D_ecustom--NumberOfSharesSold_iI_c20230403__dei--LegalEntityAxis__custom--GBTTechnologiesMember_z3idzFMWMA31" title="Number of shares sold">26,000,000</span> common shares (“Shares”) to Seller.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 18, 2023, TREN changed its name to Avant Technologies, Inc. and its ticker symbol on OTC Markets was changed to AVAI.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Potential IP’s Sale</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Effective as of March 20, 2024, Tokeniz, entered into a Patent Purchase Agreement with VisionWave Technologies Inc. (“VisionWave”) pursuant to which VisionWave agreed to acquire from Tokenize the entire right, title, and interest of certain patents and patent applications providing an intellectual property basis for a machine learning driven technology that controls radio wave transmissions, analyzes their reflections data, and constructs 2D/3D images of stationary and in motion objects (“VisionWave PPA”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #1D2838">The Purchase Price for the asset is $<span id="xdx_90C_ecustom--PurchasePrice_c20240319__20240320__dei--LegalEntityAxis__custom--VisionWaveHoldingsMember_z9qcTIOmmmb5" title="Purchase price">30,000,000</span> (the “Purchase Price”), which VisionWave will pay with shares of common stock, $0.0001 par value per share (the “Common Stock”). The Parties agree that the final Purchase Price may be adjusted and will be governed by a valuation report issued by a professional third party (“Valuation”). If the final Purchase Price per Valuation is less than $<span id="xdx_904_ecustom--PurchasePrice_c20240319__20240320__us-gaap--BusinessAcquisitionAxis__custom--TokenizeMember_zHVO0OCfowHh" title="Purchase price">30,000,000</span>, Tokenize has the option to cancel this Agreement. In accordance therewith, VisionWave agreed to issue and deliver to Tokenize, 1,000 shares of Common Stock (the “Shares”) representing 50% of VisionWave’s issued and outstanding shares of Common Stock, where the remainder of the 50% of VisionWave’s issued and outstanding shares of Common Stock are owned by a corporation controlled by Stanley Hills. Effective June 4, 2024 Tokenize been issued additional 222 shares from VisionWave for consideration of 10 million AVAI shares that been vested under VisionWave name.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #1D2838"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify; background-color: white">On March 26, 2024, Bannix Acquisition Corp., a Delaware corporation (“Bannix”), entered into a Business Combination Agreement (the “Original Agreement”), by and among Bannix, VisionWave Technologies, Inc., a Nevada corporation (“Target”) and the shareholders of Target.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On September 6, 2024, Bannix entered into a Merger Agreement and Plan of Reorganization (the “Merger Agreement”), by and among Bannix, VisionWave Holdings, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Bannix (“VisionWave Holdings”), BNIX Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of VisionWave Holdings (“Parent Merger Sub”), BNIX VW Merger Sub, Inc., a Nevada corporation and direct, wholly owned subsidiary of VisionWave, and Target. The Merger Agreement and the transactions contemplated thereby were approved by the boards of directors of each of Bannix, VisionWave Holdings, Parent Merger Sub, Company Merger Sub, and Target.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><i>The Mergers</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Pursuant to and in accordance with the terms set forth in the Merger Agreement, (a) Parent Merger Sub will merge with and into Bannix, with Bannix continuing as the surviving entity (the “Parent Merger”), as a result of which, (i) Bannix will become a wholly owned subsidiary of VisionWave Holdings, and (ii) each issued and outstanding security of Bannix immediately prior to the effective time of the Parent Merger (the “Parent Merger Effective Time”) (other than shares of Bannix Common Stock that have been redeemed or are owned by Bannix or any of its direct or indirect subsidiaries as treasury shares and any Dissenting Parent Shares) shall no longer be outstanding and shall automatically be cancelled in exchange for the issuance to the holder thereof of a substantially equivalent security of VisionWave Holdings (other than the Parent Rights, which shall be automatically converted into shares of VisionWave Holdings), and, (b) immediately following the consummation of the Parent Merger but on the same day, Company Merger Sub will merge with and into Target, with Target continuing as the surviving entity (the “Company Merger” and, together with the Parent Merger, the “Mergers”), as a result of which, (i) Target will become a wholly owned subsidiary of VisionWave Holdings, and (ii) each issued and outstanding security of Target immediately prior to the effective time of the Company Merger (the “Company Merger Effective Time”) (other than any Cancelled Shares or Dissenting Shares) shall no longer be outstanding and shall automatically be cancelled in exchange for the issuance to the holder thereof of a substantially equivalent security of VisionWave Holdings. The Mergers and the other transactions contemplated by the Merger Agreement are hereinafter referred to as the “Business Combination.”</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Subject to a six month extension the termination date by which the Company must consummate a business combination from September 14, 2024, the date that is 36 months from the closing date of the Company’s initial public offering of units, to March 14, 2025, the Business Combination is expected to close in the first quarter of 2025, subject to customary closing conditions, including the satisfaction of the minimum available cash condition, the receipt of certain governmental approvals and the required approval by the stockholders of Bannix and Target.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><i>Consideration</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Pursuant to and in accordance with the terms set forth in the Merger Agreement, at the Parent Merger Effective Time, (a) each share of Bannix common stock, par value $0.001 per share (“Bannix Common Stock”) outstanding immediately prior to the Parent Merger Effective Time that has not been redeemed, is not owned by Bannix or any of its direct or indirect subsidiaries as treasury shares and is not a Dissenting Parent Share will automatically convert into one share of common stock, par value $0.001, of VisionWave Holdings (each, a share of “VisionWave Holdings Common Stock”), (b) each Bannix Warrant shall automatically convert into one warrant to purchase shares of VisionWave Holdings Common Stock (each, a “VisionWave Holdings Warrant”) on substantially the same terms and conditions; and (c) each Bannix Right will be automatically converted into the number of shares of VisionWave Holdings Common Stock that would have been received by the holder of such Bannix Right if it had been converted upon the consummation of a business combination in accordance with Bannix’s organizational documents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In accordance with the terms and subject to the conditions of the Merger Agreement, at the Company Merger Effective Time, (a) each share of issued and outstanding Target common stock, par value $<span id="xdx_901_eus-gaap--SharePrice_iI_c20240930__dei--LegalEntityAxis__custom--VisionWaveHoldingsMember__us-gaap--StatementClassOfStockAxis__custom--TargetCommonStockMember_zm4tUS9OEbQk" title="Share price">0.01</span> (“Target Common Stock”), shall be cancelled and converted into <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20240101__20240930__dei--LegalEntityAxis__custom--VisionWaveHoldingsMember__us-gaap--StatementClassOfStockAxis__custom--TargetCommonStockMember_zdVSdCcIOrk1" title="Shares issued upon conversion">4,041</span> shares of VisionWave Holdings Common Stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; background-color: white">Subject of closing the transaction, the Company and Tokenize holdings will exchange their holdings in VW for about <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20240101__20240930__dei--LegalEntityAxis__custom--VisionWaveHoldingsMember_zoRv1Ui5bAw5" title="Shares issued upon exchange">2,917,708</span> new shares of VisionWave Holdings, represent about 20.47% of VisionWave Holdings post-closing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; background-color: white; color: #212529"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Service Agreement</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 24, 2023, the Company entered into a service agreement with Pacific Capital Markets LLC, where <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230223__20230224__dei--LegalEntityAxis__custom--PacificCapitalMarketsLLCMember__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_z63HyrzPzhgb" title="Number of shares issued, shares">100,000,000</span> Shares issued to it for certain for service agreement between Pacific Capital Markets LLC. and the Company. The value of the shares of $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230223__20230224__dei--LegalEntityAxis__custom--PacificCapitalMarketsLLCMember__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_z1B1CuU9vuYd" title="Number of shares issued, value">80,000</span> was determined based on the stock price of the Company’s common stock at grant date of $<span id="xdx_90C_ecustom--GrantPerShare_iI_c20230224__dei--LegalEntityAxis__custom--PacificCapitalMarketsLLCMember__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_zdYdAm9x39R3" title="Grant per share">0.0008</span> per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Representation Agreement</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 17, 2023, Tokenize, which is <span id="xdx_90E_ecustom--MinorityInterestsOwnershipPercentageByParent_iI_dp_c20230817__us-gaap--BusinessAcquisitionAxis__custom--TokenizeMember_z1qlUlHmInkf" title="Ownership percentage">50</span>% owned of the Company, which provided its consent, entered into a Representation Agreement (the ‘RA’) with IDL Concepts, LLC (the ‘Agent’) , to represent Tokenize in a potential purchase transaction facilitated by the Agent transferring all of Tokenize’s right, title, and interest in certain Assigned Patent Rights, as defined in the RA, free and clear of any restrictions, liens, claims, and encumbrances, and may include rights to technology and software developed by Tokenize. Tokenize owns certain provisional patent applications, patent applications, patents, and/or related foreign patents and applications, and wishes potentially to sell all right, title, and interest in such patents and applications and the causes of action to sue for infringement thereof and other enforcement rights. Tokenize will pay Agent a commission of 20% of any proceeds of any closed transaction under this RA, including all cash, equity payments and any other form of consideration upon a sale, or any monetization activity under the RA. The RA carved out certain intellectual properties held by Tokenize that Tokenize is in active negotiation with third parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-301481439	usd
CY2024Q3	GTCH	Working Capital Deficits WorkingCapitalDeficits	16029247	usd
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001731122-24-001804-index-headers.html	Edgar Link	pending
0001731122-24-001804-index.html	Edgar Link	pending
0001731122-24-001804.txt	Edgar Link	pending
0001731122-24-001804-xbrl.zip	Edgar Link	pending
e6118_10q.htm	Edgar Link	pending
e6118_ex31-1.htm	Edgar Link	pending
e6118_ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gtch-20240930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
gtch-20240930_cal.xml	Edgar Link	unprocessable
gtch-20240930_def.xml	Edgar Link	unprocessable
gtch-20240930_lab.xml	Edgar Link	unprocessable
gtch-20240930_pre.xml	Edgar Link	unprocessable
e6118_10q_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GTCH
GBT Technologies Inc. Stock $gtch

2024 Q4 Form 10-Q Financial Statement

#000173112224001804 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTCH GBT Technologies Inc. Stock $gtch

2024 Q4 Form 10-Q Financial Statement

#000173112224001804 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTCH
GBT Technologies Inc. Stock $gtch